| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Genelux Corporation (GNLX) has 11 insiders with recent SEC Form 4 filings, including 8 buys and 5 sells. GNLX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 534.8K | $1.56M | - | |
| Dir | 472.8K | $1.38M | -10,000 | |
| Other | 275.0K | $803.0K | - | |
| Other | 270.0K | $788.4K | - | |
| Other | 155.2K | $453.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Zindrick Thomas | President And CEO | Buy | 200,000 | $0.00 | - | New | -25.4% | -12.1% | |
| May 29, 2024 | Smalling Ralph52 | Head Of Regulatory | Buy | 1,250 | $0.00 | - | +10.4% | -25.4% | -12.1% | |
| May 29, 2024 | Ryder Sean52 | General Counsel | Buy | 10,000 | $0.00 | - | +1,748% | -25.4% | -12.1% | |
| May 29, 2024 | Zak Lourie S. | Chief Financial Officer | Buy | 31,250 | $0.00 | - | New | -25.4% | -12.1% | |
| May 29, 2024 | Mirabelli Mary | Director | Buy | 8,000 | $0.00 | - | +179.4% | -25.4% | -12.1% | |
| May 29, 2024 | Thomas John77 | Director | Buy | 2,500 | $0.00 | - | +0.5% | -25.4% | -12.1% | |
| May 29, 2024 | Tyree James L51 | Director | Buy | 6,250 | $0.00 | - | +180.6% | -25.4% | -12.1% | |
| May 29, 2024 | Smither John W65 | Director | Buy | 6,250 | $0.00 | - | +90.3% | -25.4% | -12.1% | |
| May 15, 2024 | Szalay Aladar78 | 10% Owner | Sell | 35,966 | $3.62 | $130,376.62 | -1.0% | -43.4% | -33.5% | |
| May 8, 2024 | Szalay Aladar78 | 10% Owner | Sell | 19,944 | $3.78 | $75,299.82 | -0.8% | -51.7% | -24.8% |